抗体产品-第178页-西安迈博睿（Mabioway）生物科技有限公司

当前分类：抗体产品

| 下级分类：

Item	Cat. No.	Type	Clone No
Anti-IgY mAbs [AbAb01-CIgY](MABL-2012)	MABL-2012	dot blot, WB, ELISA, FC, IF	Engineer antibody
Anti-IgY heavy chain mAbs [AMY-9](MABL-2013)	MABL-2013	WB, ELISA	Engineer antibody
Anti-IL-10 mAbs [2H4](MABL-2014)	MABL-2014	ELISA	Engineer antibody
Anti-IL-10 mAbs [3F5](MABL-2015)	MABL-2015	ELISA	Engineer antibody
Anti-IL-10 mAbs [9D7](MABL-2016)	MABL-2016	crystallisation, IP, Neutralisation, ELISA, IF, IHC	Engineer antibody
Anti-IL-10 mAbs [AbAb01-IL10](MABL-2017)	MABL-2017	ELISA	Engineer antibody
Anti-IL-10 mAbs [AbAb02-IL10](MABL-2018)	MABL-2018	ELISA	Engineer antibody
Anti-IL-10 mAbs [JES3-9D7](MABL-2019)	MABL-2019	Cytokine Neutralization Assay, ELISpot capture antibody, IHC-P, WB, ELISA	Engineer antibody
Anti-IL-10R mAbs [1B1.3a](MABL-2020)	MABL-2020	Blocking, FC	Engineer antibody
Anti-IL-12 mAbs [12E3](MABL-2021)	MABL-2021	ELISA	Engineer antibody
Anti-IL-12 mAbs [7G11](MABL-2022)	MABL-2022	ELISA	Engineer antibody
Anti-IL-12/IL-23p40 mAbs [CNTO 1275 (Ustekinumab)](MABL-2023)	MABL-2023	in vivo, therapeutic, Block	Engineer antibody
Anti-IL-12RB2 mAbs [IL12Rb2#1](MABL-2024)	MABL-2024	FACS, inhibition, SPR, ELISA	Engineer antibody
Anti-IL-12RB2 mAbs [IL12Rb2#2](MABL-2025)	MABL-2025	FACS, inhibition, SPR, ELISA	Engineer antibody
Anti-IL-13 mAbs [13-62](MABL-2026)	MABL-2026	ELISA	Engineer antibody
Anti-IL-13 mAbs [6A1](MABL-2027)	MABL-2027	inhibition, neutralization, SPR, ELISA	Engineer antibody
Anti-IL-13 mAbs [CNTO607](MABL-2028)	MABL-2028	neutralize, ELISA	Engineer antibody
Anti-IL-13 mAbs [DOM10-53-616](MABL-2029)	MABL-2029	neutralize, ELISA	Engineer antibody
Anti-IL-13 mAbs [M1295](MABL-2030)	MABL-2030	neutralize, therapeutic, ELISA	Engineer antibody
Anti-IL-15 mAbs [M4-7](MABL-2031)	MABL-2031	neutralizing, WB, ELISA	Engineer antibody

首页上一页 173 174 175 176 177 178 179 180 181 182 183 下一页末页